People | June 01, 2022
Tetra Bio-Pharma appoints CFO
Auld is a seasoned Financial Executive with over 30 years of relevant experience
Auld is a seasoned Financial Executive with over 30 years of relevant experience
Glofitamab has the potential to offer a readily available, fixed-duration CD20xCD3 bispecific antibody treatment approach for people with aggressive lymphoma
A seasoned professional, he will lead the strategy and business operations of Cadila’s branded prescriptions pharma business
AKS-452 is currently undergoing Phase II/III clinical testing in India as a primary vaccine; submission for Emergency Use Authorization (EUA) expected by Q3 2022
He was previously working as the CEO of IVD business at Trivitron Healthcare and drove its growth through innovation
Saumen is a postgraduate in management from IIM, Ahmedabad and an executive fellow in management from ISB, Hyderabad
He will be leading the business, operations, P&L, and growth strategy for StanPlus
Diana is a senior leader with more than 38 years of field experience in U.S. FDA’s Office of Regulatory Affairs (ORA)
During her tenure at the University of South Florida Dr. Hunter was responsible for managing the patent portfolio associated with Alzamend’s two product candidates, AL001 and AL002
Highlights the need for rebuilding, restructuring, and re-imagining resilient healthcare systems in India
Subscribe To Our Newsletter & Stay Updated
